Brand Inner
888-614-1507
En Español
En Español
Contact
Upcoming Deadline Granted by the Regulatory Board of Medical Cannabis
Arrow Down
  1. Home
    2.  » 
  2. News & Publications
    3.  » Upcoming Deadline Granted by the Regulatory Board of Medical Cannabis

Upcoming Deadline Granted by the Regulatory Board of Medical Cannabis

September 11, 2018

The budding medical cannabis industry in Puerto Rico has shown significant growth in the last few years. The Regulatory Board of Medical Cannabis (Board) of the PR Department of Health (DOH) recently announced that it is implementing Phase II of the Inventory Traceability System of medical cannabis. All authorized Crops and Manufacturing establishments must now be integrated into the System. This integration allows the supervision on inventories and security monitoring of the industry by the DOH-Medical Cannabis Office. The DOH awarded BioTrackTHC Puerto Rico (“BioTrack”) a contract to develop the System. BioTrack is currently offering three methods to introduce and transfer data to the System: (1) BioTrack’s commercial method; (2) a manual version of BioTrack’s method free of charge; and (3) access to BioTrack’s API documents in the System subject to certain limitations.

On August 1, 2018, the Board required every authorized Crop and Manufacturing establishment to be integrated into the System within a forty-five day term which expires on September 15, 2018.

Goldman Antonetti & Cordóva, LLC stands ready to assist as you and your business adjust to Puerto Rico’s regulatory and legal changes. If you need further assistance in this area, please contact the following members of our firm:

Alicia Lamboy Mombille, Esq.
787.759.4144
[email protected]

Gretchen Méndez, Esq.
787.759.4207
gmendez[email protected]

Disclaimer:

Although the information included in this document may concern legal issues, it is not a legal opinion or professional advice and clients shall not use it as such. We assume no responsibility or liability of any kind for any information contained herein, and we expressly disclaim all liability for any claim for damages arising from the use, reference to, or reliance on, such information. If legal or other expert assistance is required, the services of a competent professional should be sought.

Goldman Antonetti & Cordóva, LLC | 787-759-8000 | www.gaclaw.com